<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31112018</article-id><article-id pub-id-type="pmc">6852460</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2018-0127</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Prevalence of Carotid Stenosis and Incidence of Ischemic Stroke in
Patients Undergoing Non-Coronary Cardiac Surgery</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9377-9495</contrib-id><name><surname>da Costa</surname><given-names>Mario Augusto Cray</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Nadal</surname><given-names>Jo&#x000e3;o Paulo</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Okamoto</surname><given-names>Jefferson Matsuiti</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Betero</surname><given-names>Andr&#x000e9; Luis</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Schafranski</surname><given-names>Marcelo Derbli</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Gomes</surname><given-names>Ricardo Zanetti</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Reis</surname><given-names>Elise Souza dos Santos</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib></contrib-group><aff id="aff1">
<label>1</label>Universidade Estadual de Ponta Grossa, Departamento de Medicina,
Campus Uvaranas Medicina, Ponta Grossa, PR, Brazil.</aff><author-notes><corresp id="c1">Correspondence Address: <bold>Mario Augusto Cray da Costa</bold>,
<ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0001-9377-9495">https://orcid.org/0000-0001-9377-9495</ext-link>, Universidade Estadual de
Ponta Grossa &#x02013; Campus Uvaranas Medicina Av. General Carlos Cavalcanti, 4748 &#x02013;
Ponta Grossa, PR, Brazil Zip code: 84030-900. E-mail:
<email>drmarioaugusto@uol.com.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Sep-Oct</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Sep-Oct</season><year>2019</year></pub-date><volume>34</volume><issue>5</issue><fpage>550</fpage><lpage>559</lpage><history><date date-type="received"><day>30</day><month>4</month><year>2018</year></date><date date-type="accepted"><day>06</day><month>1</month><year>2019</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Introduction</title><p>Many publications on coronary surgery and carotid stenosis (CS) can be found,
but we do not have enough information about the relationship between
ischemic stroke, CS and non-coronary cardiac surgery.</p></sec><sec><title>Objectives</title><p>To evaluate the incidence and risk factors associated with the stroke and CS
&#x02265;50% in patients undergoing non-coronary surgeries.</p></sec><sec><title>Objectives</title><p>We assessed 241 patients, aged 40 years or older, between 2009 and 2016,
operated in Santa Casa de Miseric&#x000f3;rdia de Ponta Grossa-PR, Brazil. We
perform carotid Doppler in patients 40 years of age or older before any
cardiac surgery as a routine. The incidence and possible risk factors for CS
&#x02265;50% and perioperative stroke were analyzed by univariate statistical
analysis.</p></sec><sec><title>Results</title><p>11 patients (4.56%) presented perioperative stroke. The risk factor for
stroke was CS &#x02265;50%: OR=5.3750 (1.2909-22.3805),
<italic>P</italic>=0.0208. Eighteen patients (7.46%) had CS &#x02265;50% and
their risk factors were extracardiac arteriopathy: OR=18.6607
(6.3644-54.7143), <italic>P</italic>&#x0003c;0.0001; COPD: OR=3.9040
(1.4491-10.5179), <italic>P</italic>=0.0071; diabetes mellitus: OR=2.9844
(1.0453-8.5204), <italic>P</italic>=0.0411; recent myocardial infarction:
OR=13.8125 (1.8239-104.6052), <italic>P</italic>=0.0110; EuroSCORE II higher
<italic>P</italic>=0.0056. </p></sec><sec><title>Conclusion</title><p>The incidences of stroke and CS &#x02265;50% were 4.56% and 7.46%,
respectively. The risk factor for stroke was CS &#x02265;50% and for CS
&#x02265;50% were extracardiac arteriopathy, COPD, diabetes mellitus, recent
myocardial infarction and higher EuroSCORE II.</p></sec></abstract><kwd-group><kwd>Stroke</kwd><kwd>Cardiac Surgical Procedures</kwd><kwd>Carotid Stenosis</kwd><kwd>Valvar Disease</kwd></kwd-group></article-meta></front><body><table-wrap id="t1" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr style="background-color:#e6e7e8"><td align="left" colspan="2" rowspan="1">Abbreviations, acronyms &#x00026; symbols</td></tr></thead><tbody><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">CPB</td><td align="left" rowspan="1" colspan="1">= Cardiopulmonary bypass</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">CKD</td><td align="left" rowspan="1" colspan="1">= Chronic kidney disease</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">COPD</td><td align="left" rowspan="1" colspan="1">= Chronic obstructive pulmonary disease</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">CS</td><td align="left" rowspan="1" colspan="1">= Carotid stenosis</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">CT</td><td align="left" rowspan="1" colspan="1">= Cranial tomography</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">ECST</td><td align="left" rowspan="1" colspan="1">= European Carotid Surgery Trial</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">NASCET</td><td align="left" rowspan="1" colspan="1">= North American Symptomatic Carotid Endarterectomy
Trial</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">TIA</td><td align="left" rowspan="1" colspan="1">= Transient ischemic attack</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Many studies have correlated carotid stenosis (CS) with coronary artery disease,
coronary artery bypass grafting, and stroke risk<sup>[<xref rid="r1" ref-type="bibr">1</xref>-<xref rid="r12" ref-type="bibr">12</xref>]</sup>. Nevertheless,
the literature is poor regarding the correlation between CS and non-coronary cardiac
surgery, which may result from lack of studies in the area rather than actual
negative evidence of association.</p><p>Stroke is a complication that occurs in 2% of cardiac surgeries and remains one of
the most important causes of mortality, morbidity and increased health
expenses<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref>]</sup>. The incidence of stroke after valve surgery varies
from 2 to 17%<sup>[<xref rid="r13" ref-type="bibr">13</xref>-<xref rid="r16" ref-type="bibr">16</xref>]</sup>. Risk factors for ischemic stroke in coronary
surgery are: age &#x0003e;70 years old, female gender, systemic arterial hypertension,
diabetes mellitus, chronic kidney disease (CKD), smoking, chronic obstructive
pulmonary disease (COPD), peripheral arteriopathy, left ventricular ejection
fraction below 40%, previous stroke or transient ischemic attack (TIA), carotid
stenosis, calcified aorta, prolonged cardiopulmonary bypass (CPB), and emergency
surgery, among others<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. The
approach of patients with carotid stenosis remains controversial<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. The 2011 Guideline of the American
Heart Association recommends special care for patients with severe carotid stenosis,
cardiac surgery candidates, even if asymptomatic. That guideline recommends
performing prophylactic treatment with endarterectomy or stenting in the carotid
artery in selected cases<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>.
However, Revelo et al.<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup> when
reporting a Brazilian case series, demonstrated that patients with severe CS who
underwent intervention for treatment during the perioperative period had worse
prognosis<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>. On the
other hand, for Naylor and Bown<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>
carotid lesions would be more significant markers of stroke than associated with its
etiology, since these authors observed that groups of patients with unilateral
stenosis above 50 or 70% did not present alterations in the incidence of
stroke<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. The main
objective of this article is to demonstrate the correlation between CS and stroke in
non-coronary cardiac surgery, with the aim of evaluating: (a) the incidence of
stroke in non-coronary surgery; (b) the incidence of CS &#x02265;50% in these
patients; (c) risk factors associated with the occurrence of stroke; and (d) the
risk factors associated with CS &#x02265;50% in patients undergoing non-coronary
cardiac surgery.</p></sec><sec sec-type="methods"><title>METHODS</title></sec><sec><title>Type of Study</title><p>After approval by the Human Research Ethics Committee of Universidade Estadual de
Ponta Grossa &#x02013; Paran&#x000e1;, Brazil, report 172,980, we developed a retrospective,
observational, analytical, case-control study with information collected from a
database developed prospectively at the Cardiac Surgery Service of Santa Casa de
Miseric&#x000f3;rdia Hospital in Ponta Grossa &#x02013; Paran&#x000e1;, Brazil.</p></sec><sec><title>Sample Studied</title><p>We evaluated data from 270 patients aged &#x02265; 40 years, who underwent
non-coronary surgery at Santa Casa de Miseric&#x000f3;rdia de Ponta Grossa between
2009 and 2016. We routinely perform carotid Doppler ultrasonography in all patients
aged &#x02265; 40 years, except in urgency and emergency surgery when there is
insufficient time for examination. We excluded 29 patients with incomplete
information (especially lack of carotid Doppler), resulting in a sample of 241
patients.</p></sec><sec><title>Endpoints</title><p>We evaluated two outcomes: stroke and presence of plaque in common or internal
carotid arteries with stenosis &#x02265;50%. Those patients who did not present any
of the observed outcomes comprised the control groups of each proposed analysis.</p></sec><sec><title>Data Collection</title><p>The data were obtained from a database that had been built prospectively, forming the
database of the Cardiac Surgery Service of Santa Casa in Ponta Grossa with
preoperative, transoperative and postoperative information, which allowed us to
compose the database of EuroSCORE II<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup> along with other variables related to neurological
complications, the focus of this work. Although the study was retrospective, the
database has been developed prospectively and systematically, including all
EuroSCORE II data, carotid Doppler results, cardiopulmonary bypass and aortic
cross-clamping times, and presence of severe complications, including stroke.</p></sec><sec><title>Studied Variables</title><p>Variables endpoints: (a) presence of perioperative stroke; (b) presence of carotid
stenosis &#x02265;50% in common or internal carotid arteries. The "perioperative"
period covers the three periods of an operation: "preoperative", "transoperative"
and "postoperative", and can also be defined as the period between surgical
indication and return to the patient's activities. We considered strokes from the
time of anesthesia to hospital discharge, since preoperative stroke was unusual. The
investigation of stroke was carried out through daily evaluation of the electronic
medical record by the researchers, and we considered as a stroke the presence of
clinical symptoms lasting more than 1 hour compatible with ischemic injury
associated with change in cranial tomography (CT) as adopted by other authors.
Symptoms could be present in recovery from anesthesia, indicating a transoperative
event; or in the first hours postoperatively or later, when the patient recovers
from the anesthetic effect and then presents neurological alterations,
characterizing a postoperative event<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>. CT scan of the skull is performed immediately after the onset
of symptoms to rule out a hemorrhagic event and repeated at 24 and 48 hours
routinely, or repeated any time, in case of a change in the neurological status. As
risk factors for stroke, we analyzed the variables that make up the EuroSCORE II and
some additional ones:</p><p><list list-type="simple"><list-item><p>(a) Age (divided into &#x0003c;60 and &#x02265;60 years);</p></list-item><list-item><p>(b) Gender;</p></list-item><list-item><p>(c) Renal function divided into two groups: one group with creatinine
clearance &#x02265;85 mL/min and another group with creatinine clearance
&#x0003c;85 mL/min;</p></list-item><list-item><p>(d) Carotid stenosis &#x02265;50%: the presence of carotid lesion was
studied separately from other peripheral vascular lesions, being
considered an isolated variable, unlike the EuroSCORE II, where these
variables are grouped. Carotid exams are classified from normal to
different degrees of obstruction, according to the European Carotid
Surgery Trial method, which uses the Doppler to perform the
measurements<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>. For the statistical calculation of the present
sample, two groups of patients were considered: without stenosis or
lumen obstruction up to 49%, and stenosis with an obstruction of 50% or
more in the internal or common carotid artery on at least one
side<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>.
Patients with obstruction of 50% or more had their mean arterial blood
pressure maintained above 70 mmHg in the perioperative period;</p></list-item><list-item><p>(e) Extracardiac arteriopathy (when the patient presents with
claudication, amputation due to arterial disease in the lower limbs and
previous or planned intervention in the abdominal aorta or lower limb
arteries);</p></list-item><list-item><p>(f) Mobility severely compromised by neurological or muscular
disease;</p></list-item><list-item><p>(g) Previous cardiac surgery;</p></list-item><list-item><p>(h) Chronic obstructive pulmonary disease;</p></list-item><list-item><p>(i) Critical preoperative state: ventricular tachycardia or ventricular
fibrillation or aborted sudden death, preoperative cardiac massage,
mechanical ventilation before entering the operating room, use of
inotropic drugs prior to anesthesia or use of intra-aortic balloon,
acute kidney failure (anuria or oliguria &#x0003c;10 mL/h);</p></list-item><list-item><p>(j) Diabetes mellitus;</p></list-item><list-item><p>(k) Use of insulin;</p></list-item><list-item><p>(l) NYHA functional class divided into classes I and II against classes
III and IV;</p></list-item><list-item><p>(m) Left ventricular function considered normal (ejection fraction
&#x02265;50%) or altered (ejection fraction &#x0003c;50%). Left ventricular
(LV) function was assessed by echocardiogram, considering the ejection
fraction calculated by Teicholz, when there was no segmental dysfunction
and by the Simpson method in the presence of segmental dysfunction or in
the major alteration of ventricular geometry;</p></list-item><list-item><p>(n) Recent myocardial infarction (MI) within 90 days;</p></list-item><list-item><p>(o) Pulmonary hypertension (pulmonary systolic artery pressure &#x0003e;30
mmHg);</p></list-item><list-item><p>(p) Elective or urgency/emergency procedure;</p></list-item><list-item><p>(q) Type of surgical procedure. We performed operations such as aortic
and mitral valve replacement or repair, interatrial or interventricular
communication correction, or combined procedures;</p></list-item><list-item><p>(r) Risk by EuroSCORE II: low (up to 2); moderate (2 to 4); high (4 to 6)
and very high (&#x0003e;6);</p></list-item><list-item><p>(s) Cardiopulmonary bypass (CPB) time.</p></list-item></list></p><p>These items were also considered risk factors for carotid stenosis, except for
carotid stenosis itself and CBP time.</p></sec><sec><title>Statistical Analysis</title><p>The continuous variables were presented in mean and standard deviation and the
nominal variables in absolute number and percentage, the distributions were tested
for normality. Student's t-test was used to compare means, and Fisher's test or
chi-square test with Yates correction and logistic regression was used for the
comparison of categorical variables. Values of <italic>P</italic>&#x0003c;0.05 were
considered significant.</p></sec><sec><title>RESULTS</title><p>In the analyzed series of 241 patients, the mean age was 59.37 years old, and 43.98%
(n=106) were under 60 years old. The sample consisted of 49.37% (n=119) men, out of
which 4.56% (n=11) presented perioperative stroke and 7.46% (n=18) had CS
&#x02265;50%. These and other characteristics of the sample are presented in <xref rid="t2" ref-type="table">Table 1</xref>. All cases of stroke (n=11) were
ischemic, with 27.27% (n=3) in the right brain hemisphere, 63.64% (n=7) on the left,
and 9.09% (n=1) bilateral. The mean age of patients with stroke was 61.19 years,
54.5% were men (n=6) and 27.3% (n=3) had carotid stenosis &#x02265;50% (<xref rid="t3" ref-type="table">Table 2</xref>). All stroke cases portrayed in these
patients were observed as ipsilateral to carotid lesions &#x02265;50%. The surgical
subtype with the highest incidence of stroke was aortic valve replacement with
63.63% of cases of stroke, while mitral surgeries accounted for 27.27% of all cases
of stroke, but with no statistical difference. The incidence of stroke was 6.4% and
4.2% for aortic and mitral valve surgeries, respectively. The risk factors for
stroke were compared between groups and are shown in <xref rid="t3" ref-type="table">Table 2</xref>. Among the factors evaluated, presence of carotid stenosis
&#x02265;50% was the only one presenting a statistically significant difference
(Fisher's test = 0.039, OR 5.37, 95% CI 1.29-22.3, <italic>P</italic>=0.02) (<xref rid="t3" ref-type="table">Table 2</xref>). Considering patients with CS
&#x02265;50%, half (n=9) were men, one third (n=6) had diabetes mellitus, 61.1%
(n=11) had COPD, 55.6% (n=10) had concomitant extracardiac arteriopathy, 11.1% (n=2)
had recent acute myocardial infarction (<xref rid="t4" ref-type="table">Table
3</xref>). The risk factors for the presence of CS &#x02265;50% can be observed
in <xref rid="t4" ref-type="table">Table 3</xref>, in which the statistically
significant ones were: extracardiac arteriopathy: OR=18.6607 (6.3644-54.7143),
<italic>P</italic>&#x0003c;0.0001; COPD: OR=3.9040 (1.4491-10.5179),
<italic>P</italic>=0.0071; diabetes mellitus: OR=2.9844 (1.0453-8.5204),
<italic>P</italic>=0.0411; recent MI: OR=13.8125 (1.8239-104.6052),
<italic>P</italic>=0.0110. Higher EuroSCORE II was also associated with a higher
incidence of CS &#x02265;50%, which was 2.5% in EuroSCORE II &#x0003c; 2, 8.5% when
between 2 and 4 and 20.8% when &#x0003e; 4.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 1</label><caption><p>Sample characteristics.</p></caption><table frame="box" rules="all"><colgroup span="1"><col width="33%" span="1"/><col width="33%" span="1"/><col width="33%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="border-left:hidden" rowspan="1">&#x000a0;</th><th align="center" style="border-right:hidden" rowspan="1" colspan="1">Patients (n=241) n
(%)</th></tr></thead><tbody><tr><td align="left" rowspan="3" style="border-left:hidden" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">Average</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">59.37</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x0003c;60</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">106 (43.98%)</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02265;60</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">135 (56.01%)</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Gender</td><td align="center" rowspan="1" colspan="1">Male</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">119 (49.37%)</td></tr><tr><td align="center" rowspan="1" colspan="1">Female</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">122 (50.62%)</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Stroke</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">11 (4.56%)</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">230 (95.43%)</td></tr><tr><td align="left" rowspan="4" style="border-left:hidden" colspan="1">Creatinine
clearance</td><td align="center" rowspan="1" colspan="1">Normal (&#x02265;85)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">93 (38.58%)</td></tr><tr><td align="center" rowspan="1" colspan="1">Moderate impairment (50-85)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">119 (49.37%)</td></tr><tr><td align="center" rowspan="1" colspan="1">Severe impairment (&#x0003c;50)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">28 (11.61%)</td></tr><tr><td align="center" rowspan="1" colspan="1">Dialysis</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">1 (0.41%)</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Carotid
stenosis</td><td align="center" rowspan="1" colspan="1">&#x02265;50%</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">18 (7.46%)</td></tr><tr><td align="center" rowspan="1" colspan="1">Absence or &#x0003c;50%</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">223 (92.53%)</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Extracardiac
arteriopathy</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">24 (9.95%)</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">217 (90.04%)</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Poor
mobility</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">5 (2.07%)</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">236 (97.92%)</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Previous cardiac
surgery</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">31 (12.86%)</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">210 (87.13%)</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">COPD</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">75 (31.12%)</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">166 (68.87%)</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Critical
perioperative state</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">5 (2.07%)</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">236 (97.92%)</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Diabetes
mellitus</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">38 (14.93%)</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">203 (85.06%)</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Diabetes on
insulin</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">18 (7.46%)</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">223 (92.53%)</td></tr><tr><td align="left" rowspan="4" style="border-left:hidden" colspan="1">Functional class
(NYHA)</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">34 (14.10%)</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">25 (10.37%)</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">146 (60.58%)</td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">36 (14.93%)</td></tr><tr><td align="left" rowspan="3" style="border-left:hidden" colspan="1">Left ventricular
function</td><td align="center" rowspan="1" colspan="1">Good (&#x02265;50%)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">150 (62.24%)</td></tr><tr><td align="center" rowspan="1" colspan="1">Moderate (30-50%)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">65 (26.97%)</td></tr><tr><td align="center" rowspan="1" colspan="1">Poor (&#x0003c;30%)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">26 (10.78%)</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Recent MI</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">4 (1.65%)</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">237 (98.34%)</td></tr><tr><td align="left" rowspan="3" style="border-left:hidden" colspan="1">Pulmonary
hypertension</td><td align="center" rowspan="1" colspan="1">Absent: SPAP &#x0003c;31 mmHg</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">169 (70.12%)</td></tr><tr><td align="center" rowspan="1" colspan="1">Moderate: SPAP 31-55 mmHg</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">37 (15.35%)</td></tr><tr><td align="center" rowspan="1" colspan="1">Severe: SPAP &#x0003e;55 mmHg</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">35 (14.52%)</td></tr><tr><td align="left" rowspan="3" style="border-left:hidden" colspan="1">Urgency</td><td align="center" rowspan="1" colspan="1">Elective</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">222 (92.11%)</td></tr><tr><td align="center" rowspan="1" colspan="1">Urgency</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">15 (6.22%)</td></tr><tr><td align="center" rowspan="1" colspan="1">Emergency</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">4 (1.65%)</td></tr><tr><td align="left" rowspan="6" style="border-left:hidden" colspan="1">Type of
surgery</td><td align="center" rowspan="1" colspan="1">MV replacement</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">64 (26.55%)</td></tr><tr><td align="center" rowspan="1" colspan="1">AV replacement</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">109 (45.22%)</td></tr><tr><td align="center" rowspan="1" colspan="1">MV + AV surgery</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">19 (7.88%)</td></tr><tr><td align="center" rowspan="1" colspan="1">MV repair</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">30 (12.44%)</td></tr><tr><td align="center" rowspan="1" colspan="1">Isolated TV surgery</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">5 (2.07%)</td></tr><tr><td align="center" rowspan="1" colspan="1">ASD or VSD correction</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">14 (5.8%)</td></tr><tr><td align="left" rowspan="5" style="border-left:hidden" colspan="1">EuroSCORE
II</td><td align="center" rowspan="1" colspan="1">Average</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">3.97</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x0003c;2</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">119 (49.37%)</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02265;2 to &#x0003c;4</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">64 (26.55%)</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02265;4 to &#x02264;6</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">20 (8.29%)</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x0003e;6</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">38 (15.76%)</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>ASD=atrial septal defect; AV=aortic valve; COPD=chronic obstructive
pulmonary disease; MI=myocardial infarction; MV=mitral valve; NYHA=New
York Heart Association; SPAP=systolic pulmonary artery pressure;
TV=tricuspid valve; VSD=ventricular septal defect</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3" orientation="portrait" position="float"><label>Table 2</label><caption><p>Risk factors for stroke.</p></caption><table frame="box" rules="all"><colgroup span="1"><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="border-left:hidden" rowspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Stroke group (n=11) n (%)</th><th align="center" rowspan="1" colspan="1">Control group 1 (n=230) n (%)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> (Fisher's exact test)</th><th align="center" rowspan="1" colspan="1">OR (IC 95%)</th><th align="center" style="border-right:hidden" rowspan="1" colspan="1">
<italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="3" style="border-left:hidden" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">Average</td><td align="center" rowspan="1" colspan="1">61.19</td><td align="center" rowspan="1" colspan="1">57.60</td><td align="center" rowspan="1" colspan="1">0.05</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x0003c;60</td><td align="center" rowspan="1" colspan="1">3 (27.2%)</td><td align="center" rowspan="1" colspan="1">103 (44.8%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02265;60</td><td align="center" rowspan="1" colspan="1">8 (72.7%)</td><td align="center" rowspan="1" colspan="1">127 (55.2%)</td><td align="center" rowspan="1" colspan="1">0.3554</td><td align="center" rowspan="1" colspan="1">2.1627 (0.5595-8.3604)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.2635</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Gender</td><td align="center" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">6 (54.5%)</td><td align="center" rowspan="1" colspan="1">113 (49.1%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">5 (45.5%)</td><td align="center" rowspan="1" colspan="1">117 (50.9%)</td><td align="center" rowspan="1" colspan="1">0.7667</td><td align="center" rowspan="1" colspan="1">1.2425 (0.3688-4.1861)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.7261</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Creatinine
clearance</td><td align="center" rowspan="1" colspan="1">Normal (&#x02265;85 mL/min)</td><td align="center" rowspan="1" colspan="1">4 (36.4%)</td><td align="center" rowspan="1" colspan="1">89 (38.7%)</td><td align="center" rowspan="1" colspan="1">1.0000</td><td align="center" rowspan="1" colspan="1">1.1046 (0.3143-3.8819)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.8767</td></tr><tr><td align="center" rowspan="1" colspan="1">Impaired (&#x0003c;85 mL/min)</td><td align="center" rowspan="1" colspan="1">7 (63.6%)</td><td align="center" rowspan="1" colspan="1">141 (61.3%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Carotid
stenosis</td><td align="center" rowspan="1" colspan="1">&#x02265;50% lesion</td><td align="center" rowspan="1" colspan="1">3 (27.3%)</td><td align="center" rowspan="1" colspan="1">15 (6.5%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">Absence or &#x0003c;50% lesion</td><td align="center" rowspan="1" colspan="1">8 (72.7%)</td><td align="center" rowspan="1" colspan="1">215 (93.5%)</td><td align="center" rowspan="1" colspan="1">0.0396</td><td align="center" rowspan="1" colspan="1">5.3750 (1.2909-22.3805)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.0208</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Extracardiac
arteriopathy</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">2 (18.2%)</td><td align="center" rowspan="1" colspan="1">22 (9.6%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">9 (81.8%)</td><td align="center" rowspan="1" colspan="1">208 (90.4%)</td><td align="center" rowspan="1" colspan="1">0.3007</td><td align="center" rowspan="1" colspan="1">2.1010 (0.4268-10.3438)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.3613</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Poor
mobility</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">1 (9.1%)</td><td align="center" rowspan="1" colspan="1">4 (1.8%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">10 (90.9%)</td><td align="center" rowspan="1" colspan="1">226 (98.2%)</td><td align="center" rowspan="1" colspan="1">0.2099</td><td align="center" rowspan="1" colspan="1">5.6500 (0.5773-55.2959)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.1368</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Previous cardiac
surgery</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">3 (27.3%)</td><td align="center" rowspan="1" colspan="1">28 (12.2%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">8 (72.7%)</td><td align="center" rowspan="1" colspan="1">202 (87.8%)</td><td align="center" rowspan="1" colspan="1">0.1552</td><td align="center" rowspan="1" colspan="1">2.7054 (10.8025-0.6775)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.1589</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">COPD</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">4 (36.4%)</td><td align="center" rowspan="1" colspan="1">71 (30.9%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">7 (63.6%)</td><td align="center" rowspan="1" colspan="1">159 (69.1%)</td><td align="center" rowspan="1" colspan="1">0.7429</td><td align="center" rowspan="1" colspan="1">1.2797 (0.3630-4.5112)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.7013</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Critical
perioperative state</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">1 (9.1%)</td><td align="center" rowspan="1" colspan="1">4 (1.8%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">10 (90.9%)</td><td align="center" rowspan="1" colspan="1">226 (98.2%)</td><td align="center" rowspan="1" colspan="1">0.2099</td><td align="center" rowspan="1" colspan="1">5.6500 (0.5773-55.2959)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.1368</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Diabetes
mellitus</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">3 (27.3%)</td><td align="center" rowspan="1" colspan="1">35 (15.2%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">8 (72.7%)</td><td align="center" rowspan="1" colspan="1">195 (84.8%)</td><td align="center" rowspan="1" colspan="1">0.3868</td><td align="center" rowspan="1" colspan="1">2.0893 (0.5283-8.2620)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.2935</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Diabetes on
insulin</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">1 (9.1%)</td><td align="center" rowspan="1" colspan="1">17 (7.4%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">10 (90.9%)</td><td align="center" rowspan="1" colspan="1">213 (92.6%)</td><td align="center" rowspan="1" colspan="1">0.5822</td><td align="center" rowspan="1" colspan="1">1.2529 (0.1513-10.3779)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.8344</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">NYHA</td><td align="center" rowspan="1" colspan="1">I and II</td><td align="center" rowspan="1" colspan="1">4 (36.4%)</td><td align="center" rowspan="1" colspan="1">55 (24.0%)</td><td align="center" rowspan="1" colspan="1">0.4707</td><td align="center" rowspan="1" colspan="1">0.5500 (0.1552-1.9493)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.3544</td></tr><tr><td align="center" rowspan="1" colspan="1">III and IV</td><td align="center" rowspan="1" colspan="1">7 (63.6%)</td><td align="center" rowspan="1" colspan="1">175 (76.0%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Left ventricular
function</td><td align="center" rowspan="1" colspan="1">Normal (&#x02265;50%)</td><td align="center" rowspan="1" colspan="1">8 (72.7%)</td><td align="center" rowspan="1" colspan="1">142 (61.7%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">Impaired (&#x0003c;50%)</td><td align="center" rowspan="1" colspan="1">3 (27.3%)</td><td align="center" rowspan="1" colspan="1">88 (38.3%)</td><td align="center" rowspan="1" colspan="1">0.5416</td><td align="center" rowspan="1" colspan="1">0.6051 (0.1564-2.3419)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.4669</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Recent MI</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">1 (9.1%)</td><td align="center" rowspan="1" colspan="1">3 (1.3%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">10 (90.9%)</td><td align="center" rowspan="1" colspan="1">227 (98.7%)</td><td align="center" rowspan="1" colspan="1">0.1714</td><td align="center" rowspan="1" colspan="1">7.5667 (0.7215-79.3529)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.0915</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Pulmonary
hypertension (SPAP &#x0003e;30 mmHg)</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">7 (63.6%)</td><td align="center" rowspan="1" colspan="1">162 (70.4%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">4 (36.4%)</td><td align="center" rowspan="1" colspan="1">68 (29.6%)</td><td align="center" rowspan="1" colspan="1">0.7372</td><td align="center" rowspan="1" colspan="1">1.3613 (0.3859-4.8028)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.6315</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Urgency</td><td align="center" rowspan="1" colspan="1">Elective</td><td align="center" rowspan="1" colspan="1">10 (90.9%)</td><td align="center" rowspan="1" colspan="1">212 (92.2%)</td><td align="center" rowspan="1" colspan="1">0.6028</td><td align="center" rowspan="1" colspan="1">0.8491 (0.1028-7.0119)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.8793</td></tr><tr><td align="center" rowspan="1" colspan="1">Non-elective</td><td align="center" rowspan="1" colspan="1">1 (9.1%)</td><td align="center" rowspan="1" colspan="1">18 (7.8%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="6" style="border-left:hidden" colspan="1">Type of
surgery</td><td align="center" rowspan="1" colspan="1">MV replacement</td><td align="center" rowspan="1" colspan="1">3 (27.3%)</td><td align="center" rowspan="1" colspan="1">61 (26.5%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">AV replacement</td><td align="center" rowspan="1" colspan="1">7 (63.6%)</td><td align="center" rowspan="1" colspan="1">102 (44.3%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">MV + AV surgery</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">19 (8.2%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">MV replacement</td><td align="center" rowspan="1" colspan="1">1 (9.1%)</td><td align="center" rowspan="1" colspan="1">29 (12.6%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">TV surgery</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">5 (2.2%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">ASD or VSD</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">14 (6.1%)</td><td align="center" rowspan="1" colspan="1">0.7327</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="5" style="border-left:hidden" colspan="1">EuroSCORE
II</td><td align="center" rowspan="1" colspan="1">Average</td><td align="center" rowspan="1" colspan="1">5.38&#x000b1;7.79</td><td align="center" rowspan="1" colspan="1">3.98&#x000b1;7.14</td><td align="center" rowspan="1" colspan="1">0.5361</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x0003c;2</td><td align="center" rowspan="1" colspan="1">6 (54.5%)</td><td align="center" rowspan="1" colspan="1">113 (49.1%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">2 to 4</td><td align="center" rowspan="1" colspan="1">1 (9.1%)</td><td align="center" rowspan="1" colspan="1">63 (27.3%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">4 to 6</td><td align="center" rowspan="1" colspan="1">1 (9.1%)</td><td align="center" rowspan="1" colspan="1">19 (8.3%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x0003e;6</td><td align="center" rowspan="1" colspan="1">3 (27.3%)</td><td align="center" rowspan="1" colspan="1">35 (15.3%)</td><td align="center" rowspan="1" colspan="1">0.5006</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" style="border-left:hidden" rowspan="1" colspan="1">CPB time**</td><td align="center" rowspan="1" colspan="1">Average</td><td align="center" rowspan="1" colspan="1">106.4</td><td align="center" rowspan="1" colspan="1">112.3</td><td align="center" rowspan="1" colspan="1">0.8</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>ASD=atrial septal defect; AV=aortic valve; COPD=chronic obstructive
pulmonary disease; CPB: cardiopulmonary bypass; MI=myocardial
infarction; MV=mitral valve; NYHA=New York Heart Association;
SPAP=systolic pulmonary artery pressure; TV=tricuspid valve;
VSD=ventricular septal defect **CPB time: 162 patients, some did not
show CPB time.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t4" orientation="portrait" position="float"><label>Table 3</label><caption><p>Risk factors for carotid stenosis.</p></caption><table frame="box" rules="all"><colgroup span="1"><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="border-left:hidden" rowspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Carotid stenosis &#x02265;50% (n=18) n (%)</th><th align="center" rowspan="1" colspan="1">Control group 2 (n=223) n (%)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> (Fisher's exact test)</th><th align="center" rowspan="1" colspan="1">OR (IC 95%)</th><th align="center" style="border-right:hidden" rowspan="1" colspan="1">
<italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="3" style="border-left:hidden" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">Average</td><td align="center" rowspan="1" colspan="1">61.25</td><td align="center" rowspan="1" colspan="1">59.88</td><td align="center" rowspan="1" colspan="1">0.9</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x0003c;60</td><td align="center" rowspan="1" colspan="1">4 (22.2%)</td><td align="center" rowspan="1" colspan="1">102 (45.7%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02265;60</td><td align="center" rowspan="1" colspan="1">14 (77.8%)</td><td align="center" rowspan="1" colspan="1">121 (54.3%)</td><td align="center" rowspan="1" colspan="1">0.0817</td><td align="center" rowspan="1" colspan="1">2.9504 (0.9417-9.2439)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.0633</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Gender</td><td align="center" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">9 (50.0%)</td><td align="center" rowspan="1" colspan="1">110 (49.3%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">9 (50.0%)</td><td align="center" rowspan="1" colspan="1">113 (50.7%)</td><td align="center" rowspan="1" colspan="1">1.0000</td><td align="center" rowspan="1" colspan="1">1.0273 (0.3931-2.6843)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.9562</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Creatinine
clearance</td><td align="center" rowspan="1" colspan="1">Normal (&#x02265;85 mL/min)</td><td align="center" rowspan="1" colspan="1">3 (16.6%)</td><td align="center" rowspan="1" colspan="1">90 (40.3%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">Impaired (&#x0003c;85 mL/min)</td><td align="center" rowspan="1" colspan="1">15 (83.4%)</td><td align="center" rowspan="1" colspan="1">133 (59.6%)</td><td align="center" rowspan="1" colspan="1">0.0752</td><td align="center" rowspan="1" colspan="1">3.3835 (0.9519-12.0257)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.0596</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Extracardiac
arteriopathy</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">10 (55.6%)</td><td align="center" rowspan="1" colspan="1">14 (6.3%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">8 (44.4%)</td><td align="center" rowspan="1" colspan="1">209 (93.7%)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" rowspan="1" colspan="1">18.6607 (6.3644-54.7143</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Poor
mobility</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">1 (5.5%)</td><td align="center" rowspan="1" colspan="1">4 (1.8%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">17 (94.4%)</td><td align="center" rowspan="1" colspan="1">219 (98.2%)</td><td align="center" rowspan="1" colspan="1">0.3239</td><td align="center" rowspan="1" colspan="1">3.2206 (0.3407-30.4409)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.3075</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Previous cardiac
surgery</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">2 (11.1%)</td><td align="center" rowspan="1" colspan="1">29 (13.0%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">16 (88.9%)</td><td align="center" rowspan="1" colspan="1">194 (87.0%)</td><td align="center" rowspan="1" colspan="1">1.0000</td><td align="center" rowspan="1" colspan="1">0.8362 (0.1827-3.8268)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.8177</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">COPD</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">11 (61.1%)</td><td align="center" rowspan="1" colspan="1">64 (28.7%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">7 (38.9%)</td><td align="center" rowspan="1" colspan="1">159 (71.3%)</td><td align="center" rowspan="1" colspan="1">0.0071</td><td align="center" rowspan="1" colspan="1">3.9040 (1.4491-10.5179)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.0071</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Critical
perioperative state</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">5 (2.2%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">18 (100%)</td><td align="center" rowspan="1" colspan="1">218 (97.8%)</td><td align="center" rowspan="1" colspan="1">1.0000</td><td align="center" rowspan="1" colspan="1">1.0737 (0.0571-20.1837)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.9621</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Diabetes
mellitus</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">6 (33.3%)</td><td align="center" rowspan="1" colspan="1">32 (14.3%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">12 (66.6%)</td><td align="center" rowspan="1" colspan="1">191 (85.7%)</td><td align="center" rowspan="1" colspan="1">0.0450</td><td align="center" rowspan="1" colspan="1">2.9844 (1.0453-8.5204)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.0411</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Diabetes on
insulin</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">2 (11.1%)</td><td align="center" rowspan="1" colspan="1">16 (7.2%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">16 (88.9%)</td><td align="center" rowspan="1" colspan="1">207 (92.8%)</td><td align="center" rowspan="1" colspan="1">0.6315</td><td align="center" rowspan="1" colspan="1">1.6172 (0.3414-7.6613)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.5447</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">NYHA</td><td align="center" rowspan="1" colspan="1">I and II</td><td align="center" rowspan="1" colspan="1">1 (5.6%)</td><td align="center" rowspan="1" colspan="1">58 (26%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">II and IV</td><td align="center" rowspan="1" colspan="1">17 (94.4%)</td><td align="center" rowspan="1" colspan="1">165 (74%)</td><td align="center" rowspan="1" colspan="1">0.0824</td><td align="center" rowspan="1" colspan="1">5.9758 (0.7779-45.9065)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.0857</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Left ventricular
function</td><td align="center" rowspan="1" colspan="1">Normal (&#x02265;50%)</td><td align="center" rowspan="1" colspan="1">10 (55.5%)</td><td align="center" rowspan="1" colspan="1">140 (62.8%)</td><td align="center" rowspan="1" colspan="1">0.6158</td><td align="center" rowspan="1" colspan="1">1.3494 (0.5123-3.5545)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.5442</td></tr><tr><td align="center" rowspan="1" colspan="1">Impaired (&#x0003c;50%)</td><td align="center" rowspan="1" colspan="1">8 (44.5%)</td><td align="center" rowspan="1" colspan="1">83 (37.2%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Recent MI</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">2 (11.1%)</td><td align="center" rowspan="1" colspan="1">2 (0.9%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">16 (88.9%)</td><td align="center" rowspan="1" colspan="1">221 (99.1%)</td><td align="center" rowspan="1" colspan="1">0.0289</td><td align="center" rowspan="1" colspan="1">13.8125 (1.8239-104.6052)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.0110</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Pulmonary
hypertension (SPAP &#x0003e;30 mmHg)</td><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">14 (77.7%)</td><td align="center" rowspan="1" colspan="1">155 (69.5%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">4 (22.3)</td><td align="center" rowspan="1" colspan="1">68 (30.5%)</td><td align="center" rowspan="1" colspan="1">0.5967</td><td align="center" rowspan="1" colspan="1">0.6513 (0.2068-2.0511)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.4638</td></tr><tr><td align="left" rowspan="2" style="border-left:hidden" colspan="1">Urgency</td><td align="center" rowspan="1" colspan="1">Elective</td><td align="center" rowspan="1" colspan="1">17 (94.4%)</td><td align="center" rowspan="1" colspan="1">205 (91.9%)</td><td align="center" rowspan="1" colspan="1">1.0000</td><td align="center" rowspan="1" colspan="1">0.6699 (0.084205.3282)</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">0.7050</td></tr><tr><td align="center" rowspan="1" colspan="1">Non-elective</td><td align="center" rowspan="1" colspan="1">1 (5.5%)</td><td align="center" rowspan="1" colspan="1">18 (8.1%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="6" style="border-left:hidden" colspan="1">Type of
surgery</td><td align="center" rowspan="1" colspan="1">MV replacement</td><td align="center" rowspan="1" colspan="1">3 (16.6%)</td><td align="center" rowspan="1" colspan="1">61 (27.3%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">AV replacement</td><td align="center" rowspan="1" colspan="1">10 (55.5%)</td><td align="center" rowspan="1" colspan="1">99 (44.4%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">MV + AV surgery</td><td align="center" rowspan="1" colspan="1">3 (16.6%)</td><td align="center" rowspan="1" colspan="1">16 (7.2%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">MV replacement</td><td align="center" rowspan="1" colspan="1">1 (5.5%)</td><td align="center" rowspan="1" colspan="1">29 (13%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">TV surgery</td><td align="center" rowspan="1" colspan="1">1 (5.5%)</td><td align="center" rowspan="1" colspan="1">4 (1.8%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">ASD or VSD</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">6.3 (14%)</td><td align="center" rowspan="1" colspan="1">0.2978</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="5" style="border-left:hidden" colspan="1">EuroSCORE
II</td><td align="center" rowspan="1" colspan="1">Average</td><td align="center" rowspan="1" colspan="1">6.08</td><td align="center" rowspan="1" colspan="1">3.77</td><td align="center" rowspan="1" colspan="1">0.74</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x0003c;2</td><td align="center" rowspan="1" colspan="1">3 (1.6%)</td><td align="center" rowspan="1" colspan="1">116 (52%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02265;2 to &#x0003c;4</td><td align="center" rowspan="1" colspan="1">5 (2.8%)</td><td align="center" rowspan="1" colspan="1">59 (26.4%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x02265;4 to &#x02264;6</td><td align="center" rowspan="1" colspan="1">4 (2.2%)</td><td align="center" rowspan="1" colspan="1">16 (7.2%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x0003e;6</td><td align="center" rowspan="1" colspan="1">6 (1.8%)</td><td align="center" rowspan="1" colspan="1">32 (14.3%)</td><td align="center" rowspan="1" colspan="1">0.0056</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" style="border-right:hidden" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p>ASD=atrial septal defect; AV=aortic valve; COPD=chronic obstructive
pulmonary disease; MI=myocardial infarction; MV=mitral valve; NYHA=New
York Heart Association; SPAP=systolic pulmonary artery pressure;
TV=tricuspid valve; VSD=ventricular septal defect</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>While the vast majority of studies deal with the incidence of stroke in patients
undergoing coronary artery bypass graft surgery, few are concerned with evaluating
the incidence of stroke in other populations, such as those submitted to
non-coronary surgery, such as valve and congenital surgeries in adults. This article
is the first in a comprehensive review of the literature addressing the relationship
between carotid stenosis, stroke and non-coronary cardiac surgery.</p><p>In Brazilian services, the number of degenerative valve diseases has been increasing,
in addition to a high prevalence of rheumatic diseases, resulting in a large number
of valve surgeries in the country. Therefore, an investigation of the predisposing
causes of stroke in this population is justified<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup>. Studies performed with students in some
Brazilian capitals have estimated the prevalence of chronic rheumatic heart disease
in 1-7 cases/1,000 students, which is significantly higher than the prevalence of
the disease in developed countries, such as the United States, where it varies
between 0.1 and 0.4 cases/1,000 students<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup>.</p><p>Stroke is a complication that occurs in 2% of cardiac surgeries. It remains one of
the most important causes of mortality and morbidity and is responsible for a great
increase in health expenses<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref></sup>. The incidence of 4.56% neurological
ischemic events in this article is similar to that described in 2001 by Bucerius et
al., who observed a rate of 4.6% of neurological injury after cardiac
surgery<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>. However, it
is important to emphasize the difference between the populations addressed by this
study and by Bucerius et al.<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>
In this study, we considered only the ischemic events with stroke documented by CT
image and compatible clinical condition in patients over 40 years old and
non-coronary surgery, whereas that study includes strokes and TIAs in all types of
surgery at different ages.</p><p>In 2012, Roffi et al.<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup> observed
that in coronary surgeries stroke occurs in the first hours of the perioperative
period (from anesthesia to anesthetic recovery) in 45% of cases and on the second
day onwards in 55% of the cases. Early embolism might occur due to manipulation of
the heart and aorta or particles carried by CPB; late events may be related to
atrial fibrillation, myocardial infarction, low output, and
hypercoagulability<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>.</p><p>Patients with carotid stenosis have an increased incidence of ischemic stroke,
however, embolism remains the leading cause of ischemic events, 62% according to
Selim, even among patients with carotid disease<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>. In this sample, the presence of CS &#x02265;50% was the
only risk factor associated with stroke, 27.3% of the patients with CS &#x02265;50%
developed ischemic stroke at some time in the perioperative period, demonstrating a
strong association between stenosis and neurological damage.</p><p>In a study involving risk of stroke in coronary and non-coronary surgery, Costa et
al.<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup> showed that
carotid stenosis &#x02265;70% was found in 3.47% of the patients and &#x02265;50% in
9.63% of the patients studied. Patients without carotid stenosis or with lesions
&#x0003c;50% presented 3.6% of stroke, while patients with lesions &#x02265; 50% and
&#x02265;70% showed 10 and 20% of strokes, respectively. The risk factors for stroke
were CS &#x02265;70%, peripheral artery disease and the presence of diabetes in
insulin use<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>.</p><p>It is commonly accepted that the progression of carotid stenosis is related to
atherosclerotic plaque instability, and, consequently, increased risk of
stroke<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. Sabatei et al.
found that the progression of carotid stenosis was associated with a 2.5% to 5%
increase in the risk of developing stroke in the first three years<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>, while Kakkos et al.<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup> demonstrated that the risk of
ipsilateral stroke over the next eight years in asymptomatic patients with plaque
progression was 16%. Hirt described in an article the relationship between CS and
the occurrence of an ipsilateral neurological event, and the annual advance of
stenosis was 5.2% per year for the entire cohort. The progression of stenosis was
associated with a five-fold increase in ipsilateral stroke risk for the following
year, especially for categories above 50% of obstruction<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup>. Naylor and Bown<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>, in a complex and extensive meta-analysis,
demonstrated that symptomatic or non-symptomatic patients with CS &#x02265;50%
presented a 7.4% risk of stroke, and this risk increased to 9.1% with lesions
greater than 80%.</p><p>Regarding patients with previous stroke, when TIA or carotid occlusion were excluded,
the risk fell to 3.8% in a lesion of 50 to 99% and 2% in a lesion of 70 to 99%. The
incidence of ipsilateral stroke in a patient with asymptomatic unilateral lesion
between 50 and 99% was 2% and the risk of any stroke was 2.9%. This risk did not
increase with the severity of stenosis from 70 to 99% &#x000d7; 80 to 99%. Patients
with asymptomatic bilateral CS with lesions between 50 and 99% or lesions of 50 to
99% with contralateral occlusion had a 6.5% risk of stroke after cardiac
surgery<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. In this study,
the surgical subtype that presented the highest incidence of stroke was aortic valve
replacement, however, no statistical difference was observed, and we did not find
data in the literature that could be compared with these results.</p><p>In our hospital a line of research in cardiac surgery and cerebrovascular disease has
been implemented, and the use of Doppler in all patients over 40 years submitted to
cardiac surgery is part of the routine. However, outside the research environment,
it is necessary to evaluate the cost-effectiveness of carrying out this procedure
routinely. The detection of carotid disease is known to be a risk marker and may
also be a cause of stroke. The use of carotid Doppler in the preoperative period of
patients undergoing coronary surgery is well accepted, however there are no studies
evaluating its use in non-coronary heart surgery. The indiscriminate use of carotid
Doppler could only add cost without significant benefit. This series used the
carotid Doppler routinely in all patients over 40 years old and showed carotid
stenosis in 7.46% of the cases, requiring 13 examinations to detect a patient with
the alteration. However, when assessing risk factors, the risk of carotid lesion was
seen to increase significantly in the presence of diabetes mellitus, COPD, recent MI
and extracardiac arteriopathy, which are markers of atherosclerosis as a whole. This
seems to point to the need to routinely perform carotid Doppler in the presence of
any of these risk factors.</p><p>It is worth mentioning that renal dysfunction showed a trend of significance with
<italic>P</italic>=0.05. In a sample enlargement it might also become a risk
marker. The increased EuroSCORE II was also associated with a higher incidence of
carotid injury, noting that CS alone increases the EuroSCORE II value.
Interestingly, there was no statistical difference between the mean age of patients
with or without CS &#x02265;50% (61.25 and 59.88 years, respectively), which can be
attributed to the small sample size.</p><p>The relationship between CS and stroke is undeniable considering the available
evidence, but it is very controversial whether plaque is the cause or a risk marker
for stroke, since patients with carotid atherosclerotic disease may have severe
atherosclerotic disease of the ascending aorta, which is an important cause of
embolic stroke<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup>. Subgroup
analysis of the European Carotid Surgery Trial (ECST) and the North American
Symptomatic Carotid Endarterectomy Trial (NASCET) have shown that the severity of
stenosis (but non-occlusion) is a predictive risk factor for stroke in patients
undergoing surgical treatment<sup>[<xref rid="r25" ref-type="bibr">25</xref>,<xref rid="r26" ref-type="bibr">26</xref>]</sup>. The results found in our study
suggest that carotid lesions are associated to stroke. Nevertheless, they could not
be confirmed as its etiology. The number of patients with carotid injury and stroke
was small, only three cases. Although stroke was ipsilateral to the carotid lesion
in these three patients, this does not establish a causal relationship.</p><p>The importance of aortic manipulation as a cause of stroke is known; plaques can
rupture during cannulation and aortic clamping. Since open valve surgeries depend on
CPB, these procedures cannot be avoided. Special care in handling the aorta mainly
in the presence of calcification may minimize embolization, although many times the
plaques may be soft and undetectable by the surgeon during the procedure. Strategies
to avoid aortic manipulation in coronary surgeries are gaining ground with increased
surgeon concern about the stroke outcome and its serious consequences. These
strategies include non-CPB surgery and proximal anastomosis of internal thoracic
artery grafts, avoiding periods of low output, treatment of arrhythmias, less use of
CPB, avoiding transoperative hyperglycemia, improving cerebral oxygenation,
endarterectomy and prior angioplasty in patients with severe carotid
stenosis<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r27" ref-type="bibr">27</xref>,<xref rid="r28" ref-type="bibr">28</xref>]</sup>.</p><p>In valve surgery, in addition to avoiding clamping and cannulation in regions of
plaques, surgeons should be careful with calcium fragments, being routine in this
service to wash the left ventricular cavity with saline solution and carefully
aspirate it to remove small pieces of calcium that may break off in the removal of
calcified cusps. Placing gauze in the left ventricle before removal of calcified
aortic valves can also prevent pieces of calcium from falling between muscle
trabeculae without being visualized.</p><p>These precautions may be useful, but it is necessary to alert surgical teams more
consistently to the need for strategies to reduce the incidence of stroke in
non-coronary operations. Strategies that seek to determine patients at greatest risk
for stroke can assist the surgeon in conducting the procedure. The search for
atherosclerosis markers may select patients at increased risk of stroke and guide
that conduct. In addition to plaques in the aorta and stenosis in the extracranial
carotid arteries, other factors interfere with cerebral perfusion, such as
intracranial atherosclerosis. Therefore, maintaining adequate blood pressure and
oxygenation is essential to avoid prolonged shock or significant hypoxemia, which
can lead to brain damage. In our service, it is common practice to maintain mean
arterial pressure above 70 mmHg in patients at increased risk of stroke, especially
in patients with an important carotid injury, in addition to careful choice of
cannulation site and aortic clamping.</p><p>Prophylactic treatment of severe carotid lesions in patients without neurological
symptoms undergoing cardiac surgery is still controversial. Touze et al.<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup> reported that patients over 75
years of age and with severe bilateral carotid stenosis undergoing prophylactic
carotid artery endarterectomy, that is, before cardiac surgery, had a 12% incidence
of stroke after cardiac procedure. In 2012, Barrera et al.<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup> investigated the incidence of
stroke in the postoperative period of cardiac surgery in patients with carotid
artery stenosis above 70% who underwent carotid artery stent implantation and found
that the group under study had a 6% risk of stroke and death in the first 30 days.
Revelo et al., in a Brazilian sample of 1,169 patients submitted to coronary
surgery, showed that 19.9% presented CS &#x02265;50%, 8.6% had CS &#x02265;70% and 2%
had unilateral occlusion. Among patients with severe CS who underwent intervention
for preoperative treatment, the incidence of TIA, stroke and death was 12.5%
<italic>versus</italic> 3.4% for patients not undergoing CS treatment
(<italic>P</italic>=0.24)<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>.
For Naylor and Bown, carotid lesions would be considered markers of stroke rather
than associated with its etiology, since they observed that groups of patients with
unilateral stenosis above 50% or above 70% had no change in the incidence of
stroke<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>.</p><p>The guideline of the American Heart Association recommends that all patients with
70-99% of asymptomatic carotid stenosis should receive risk control and treatment
adequacy. They recommend that highly selected patients should be treated
prophylactically with carotid artery endarterectomy or carotid artery stent when the
risk of the procedure is lower than 1%<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>. In order to identify the best practice in this group of
patients, it is necessary to carry out randomized multicenter studies with high
statistical power, comparing prophylactic strategies for endarterectomy and/or
carotid angioplasty and absence of prophylactic treatment, and taking into account
the degree of stenosis and the presence of unilateral or bilateral
carotid<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. In 2015, Kang
published a study on the effects of smoking on arterial disease including 667
patients. Those over 65 years old and smokers showed greater rupture and
inflammation in atherosclerotic plaques, regardless of the plaque site, 8.3%
compared to 3.9% for nonsmokers (<italic>P</italic>=0.04)<sup>[<xref rid="r29" ref-type="bibr">29</xref>]</sup>. In the present sample, COPD can be an
inflammatory marker, inferring that there is a systemic inflammatory state triggered
by smoking, which is associated with a greater likelihood of presenting concomitant
carotid lesion, as well as a greater chance of developing extracardiac arteriopathy,
that is, in other places besides the carotid arteries. This paper presents some
limitations that should be emphasized: it is a database review and not a prospective
study, and it was conducted in a single center with a small sample. The small number
of events decreases the statistical power of the sample. In our study, we had only
11 cases of stroke, which limited the performance of the multivariate analysis, and
other larger studies are necessary for better clarification. Furthermore, we did not
know the duration of surgeries or the incidence of atrial fibrillation in the
perioperative period.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>In the result of this study the incidence of ischemic stroke was 4.56%, while the
incidence of carotid stenosis &#x02265;50% was 7.46%. The significant risk factor for
perioperative stroke in cardiac surgery was carotid stenosis &#x02265;50%, while the
factors associated with stenosis &#x02265;50% were extracardiac arteriopathy, recent
myocardial infarction, diabetes, COPD and higher EuroSCORE II.</p><table-wrap id="t5" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors&#x02019; roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">MACC</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; drafting the work or revising it critically for
important intellectual content; agreement to be accountable for all
aspects of the work in ensuring that questions related to the
accuracy or integrity of any part of the work are appropriately
investigated and resolved; final approval of the version to be
published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">JPN</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">JMO</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ALB</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MDS</td><td align="left" rowspan="1" colspan="1">Agreement to be accountable for all aspects of the work
in ensuring that questions related to the accuracy or integrity of
any part of the work are appropriately investigated and resolved;
final approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RZG</td><td align="left" rowspan="1" colspan="1">Agreement to be accountable for all aspects of the work
in ensuring that questions related to the accuracy or integrity of
any part of the work are appropriately investigated and resolved;
final approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ESSR</td><td align="left" rowspan="1" colspan="1">Agreement to be accountable for all aspects of the work
in ensuring that questions related to the accuracy or integrity of
any part of the work are appropriately investigated and resolved;
final approval of the version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="supported-by"><p>No financial support.</p></fn><fn fn-type="other"><p>This study was carried out at the Universidade Estadual de Ponta Grossa, Campus
Uvaranas Medicina, Ponta Grossa, PR, Brazil.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naylor</surname><given-names>AR</given-names></name><name><surname>Schoroeder</surname><given-names>TV</given-names></name><name><surname>Sillesen</surname><given-names>H</given-names></name></person-group><article-title>Clinical and imaging features associated with an increased risk
of late stroke in patients with asymptomatic carotid disease</article-title><source>Eur J Vasc Endovasc Surg</source><year>2014</year><volume>48</volume><issue>6</issue><fpage>633</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1016/j.ejvs.2014.08.017</pub-id><pub-id pub-id-type="pmid">25266404</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naylor</surname><given-names>AR</given-names></name><name><surname>Bown</surname><given-names>MJ</given-names></name></person-group><article-title>Stroke after cardiac surgery and its association with
asymptomatic carotid disease an updated systematic review and
meta-analysis</article-title><source>Eur J Vasc Endovasc Surg</source><year>2011</year><volume>41</volume><issue>5</issue><fpage>607</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1016/j.ejvs.2011.02.016</pub-id><pub-id pub-id-type="pmid">21396854</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roffi</surname><given-names>M</given-names></name><name><surname>Ribichini</surname><given-names>F</given-names></name><name><surname>Castriota</surname><given-names>F</given-names></name><name><surname>Cremonesi</surname><given-names>A</given-names></name></person-group><article-title>Management of combined severe carotid and coronary artery
disease</article-title><source>Curr Cardiol Rep</source><year>2012</year><volume>14</volume><issue>2</issue><fpage>125</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1007/s11886-012-0246-1</pub-id><pub-id pub-id-type="pmid">22270260</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Touze</surname><given-names>E</given-names></name><name><surname>Warlow</surname><given-names>CP</given-names></name><name><surname>Rothwell</surname><given-names>PM</given-names></name></person-group><article-title>Risk of coronary and other nonstroke vascular death in relation
to the presence and extent of atherosclerotic disease at the carotid
bifurcation</article-title><source>Stroke</source><year>2006</year><volume>37</volume><issue>12</issue><fpage>2904</fpage><lpage>2909</lpage><pub-id pub-id-type="doi">10.1161/01.STR.0000248764.51601.bb</pub-id><pub-id pub-id-type="pmid">17082473</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrera</surname><given-names>JG</given-names></name><name><surname>Kristin</surname><given-names>E</given-names></name><name><surname>Rojas</surname><given-names>BA</given-names></name><name><surname>Balestrini</surname><given-names>C</given-names></name><name><surname>Espinel</surname><given-names>C</given-names></name><name><surname>Figueredo</surname><given-names>A</given-names></name></person-group><article-title>Early results after synchronous carotid stent placement and
coronary artery bypass graft in patients with asymptomatic carotid
stenosis</article-title><source>J Vasc Surg</source><year>2012</year><volume>57</volume><issue>2 Suppl</issue><fpage>58S</fpage><lpage>63S</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2012.06.116</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabatei</surname><given-names>S</given-names></name><name><surname>Schlager</surname><given-names>O</given-names></name><name><surname>Exner</surname><given-names>M</given-names></name><name><surname>Melkusch</surname><given-names>W</given-names></name><name><surname>Amighi</surname><given-names>J</given-names></name><name><surname>Dick</surname><given-names>P</given-names></name></person-group><article-title>Progression of carotid stenosis detected by duplex
ultrasonography predicts adverse outcomes in cardiovascular high-risk
patients</article-title><source>Stroke</source><year>2007</year><volume>38</volume><issue>11</issue><fpage>2887</fpage><lpage>2894</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.107.488387</pub-id><pub-id pub-id-type="pmid">17885257</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kakkos</surname><given-names>SK</given-names></name><name><surname>Nicolaides</surname><given-names>NA</given-names></name><name><surname>Charalambous</surname><given-names>I</given-names></name><name><surname>Thomas</surname><given-names>D</given-names></name><name><surname>Giannopoulos</surname><given-names>A</given-names></name><name><surname>Naylor</surname><given-names>AR</given-names></name></person-group><article-title>Predictors and clinical significance of progression or regression
of asymptomatic carotid stenosis</article-title><source>J Vasc Surg</source><year>2014</year><volume>59</volume><issue>4</issue><fpage>956</fpage><lpage>967</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2013.10.073</pub-id><pub-id pub-id-type="pmid">24377944</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inzitari</surname><given-names>D</given-names></name><name><surname>Eliasziw</surname><given-names>M</given-names></name><name><surname>Gates</surname><given-names>P</given-names></name><name><surname>Sharpe</surname><given-names>BL</given-names></name><name><surname>Chan</surname><given-names>RKT</given-names></name><name><surname>Meldrum</surname><given-names>HE</given-names></name></person-group><article-title>The causes and risk of stroke in patients with asymptomatic
internal-carotid-artery stenosis</article-title><source>N Engl J Med</source><year>2000</year><volume>342</volume><issue>23</issue><fpage>1693</fpage><lpage>1700</lpage><pub-id pub-id-type="doi">10.1056/NEJM200006083422302</pub-id><pub-id pub-id-type="pmid">10841871</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selim</surname><given-names>M</given-names></name></person-group><article-title>Perioperative stroke</article-title><source>N Engl J Med</source><year>2007</year><volume>356</volume><issue>7</issue><fpage>706</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1056/NEJMra062668</pub-id><pub-id pub-id-type="pmid">17301301</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahmoudi</surname><given-names>M</given-names></name><name><surname>Hill</surname><given-names>PC</given-names></name><name><surname>Xue</surname><given-names>Z</given-names></name><name><surname>Torguson</surname><given-names>R</given-names></name><name><surname>Ali</surname><given-names>G</given-names></name><name><surname>Boyce</surname><given-names>SW</given-names></name></person-group><article-title>Patients with severe asymptomatic carotid artery stenosis do not
have a higher risk of stroke and mortality after coronary bypass
surgery</article-title><source>Stroke</source><year>2011</year><volume>42</volume><issue>10</issue><fpage>2801</fpage><lpage>2805</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.111.618082</pub-id><pub-id pub-id-type="pmid">21817149</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldstein</surname><given-names>LB</given-names></name><name><surname>Bushnell</surname><given-names>CD</given-names></name><name><surname>Adams</surname><given-names>RJ</given-names></name><name><surname>Appel</surname><given-names>LJ</given-names></name><name><surname>Braun</surname><given-names>LT</given-names></name><name><surname>Chatuverdi</surname><given-names>S</given-names></name></person-group><article-title>Guidelines for the primary prevention of stroke a guideline for
healthcare professionals from the American Heart Association / American
Stroke Association</article-title><source>Stroke</source><year>2011</year><volume>42</volume><issue>2</issue><fpage>517</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1161/STR.0b013e3181fcb238</pub-id><pub-id pub-id-type="pmid">21127304</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Revelo</surname><given-names>MSC</given-names></name><name><surname>Oliveira</surname><given-names>DP</given-names></name><name><surname>Arantes</surname><given-names>FBB</given-names></name></person-group><article-title>Influence of Carotid Injury in Post-Myocardial Revascularization
Surgery and Its Late Evolution</article-title><source>Arq Bras Cardiol</source><year>2013</year><volume>101</volume><issue>4</issue><fpage>297</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.5935/abc.20130183</pub-id><pub-id pub-id-type="pmid">24008654</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Udess</surname><given-names>R</given-names></name><name><surname>Solanki</surname><given-names>P</given-names></name><name><surname>Mehta</surname><given-names>A</given-names></name></person-group><article-title>Carotid artery stenosis as an independent risk factor for
perioperative strokes following mitral valve surgical
intervention</article-title><source>J Neurol Sci</source><year>2017</year><volume>382</volume><fpage>170</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1016/j.jns.2017.10.004</pub-id><pub-id pub-id-type="pmid">29055498</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filsoufi</surname><given-names>F</given-names></name><name><surname>Rahmanian</surname><given-names>PB</given-names></name></person-group><person-group person-group-type="author"><collab>Castilho JG et al.Incidence.imaging analysis.and early and late
outcomes of stroke after cardiac valve operation</collab></person-group><article-title>Am</article-title><source>J Cardiol</source><year>2008</year><volume>101</volume><issue>10</issue><fpage>1472</fpage><lpage>1478</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2008.01.029</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Mosa</surname><given-names>AF</given-names></name><name><surname>Omair</surname><given-names>A</given-names></name><name><surname>Arifi</surname><given-names>AA</given-names></name><name><surname>Najm</surname><given-names>HK</given-names></name></person-group><article-title>Mitral valve replacement for mitral stenosis a 15-years single
center experience</article-title><source>J Saudi Heart Assoc</source><year>2016</year><volume>28</volume><issue>4</issue><fpage>232</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1016/j.jsha.2016.02.007</pub-id><pub-id pub-id-type="pmid">27688670</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mess&#x000e9;</surname><given-names>SR</given-names></name><name><surname>Acker</surname><given-names>MA</given-names></name><name><surname>Kasner</surname><given-names>SE</given-names></name></person-group><article-title>Stroke after aortic valve surgery results from a prospective
cohort</article-title><source>Circulation</source><year>2014</year><volume>129</volume><issue>22</issue><fpage>2253</fpage><lpage>2261</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.113.005084</pub-id><pub-id pub-id-type="pmid">24690611</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nashef</surname><given-names>SA</given-names></name><name><surname>Roques</surname><given-names>F</given-names></name><name><surname>Sharples</surname><given-names>LD</given-names></name><name><surname>Nilsson</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>C</given-names></name><name><surname>Goldstone</surname><given-names>AR</given-names></name></person-group><article-title>EuroSCORE II</article-title><source>Eur J Cardiothorac Surg</source><year>2012</year><volume>41</volume><issue>4</issue><fpage>734</fpage><lpage>744</lpage><pub-id pub-id-type="doi">10.1093/ejcts/ezs043</pub-id><pub-id pub-id-type="pmid">22378855</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirotani</surname><given-names>T</given-names></name><name><surname>Kameda</surname><given-names>T</given-names></name><name><surname>Kumamoto</surname><given-names>T</given-names></name><name><surname>Shirota</surname><given-names>S</given-names></name><name><surname>Yamano</surname><given-names>M</given-names></name></person-group><article-title>Stroke after coronary artery bypass grafting in patients with
cerebrovascular disease</article-title><source>Ann Thorac Surg</source><year>2000</year><volume>70</volume><issue>5</issue><fpage>1571</fpage><lpage>1576</lpage><pub-id pub-id-type="doi">10.1016/S0003-4975(00)01948-2</pub-id><pub-id pub-id-type="pmid">11093489</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>European Carotid Surgery Trialists&#x00026;apos; Collaborative
Group</collab></person-group><article-title>Randomised trial of endarterectomy for recently symptomatic
carotid stenosis final results of the MRC European Carotid Surgery Trial
(ECST)</article-title><source>Lancet</source><year>1998</year><volume>351</volume><issue>9113</issue><fpage>1379</fpage><lpage>1387</lpage><pub-id pub-id-type="doi">10.1016/s0140-6736(97)09292-1</pub-id><pub-id pub-id-type="pmid">9593407</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meira</surname><given-names>ZM</given-names></name><name><surname>Goulart</surname><given-names>EM</given-names></name><name><surname>Colosimo</surname><given-names>EA</given-names></name><name><surname>Mota</surname><given-names>CC</given-names></name></person-group><article-title>Long term follow up of rheumatic fever and predictors of severe
rheumatic valvar disease in brazilian children and
adolescents</article-title><source>Heart</source><year>2005</year><volume>91</volume><issue>8</issue><fpage>1019</fpage><lpage>1022</lpage><pub-id pub-id-type="doi">10.1136/hrt.2004.042762</pub-id><pub-id pub-id-type="pmid">16020588</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bucerius</surname><given-names>J</given-names></name><name><surname>Gummert</surname><given-names>JF</given-names></name><name><surname>Borger</surname><given-names>MA</given-names></name><name><surname>Walther</surname><given-names>T</given-names></name><name><surname>Doll</surname><given-names>N</given-names></name><name><surname>Onnasch</surname><given-names>JF</given-names></name></person-group><article-title>Stroke after cardiac surgery a risk factor analysis of 16,184
consecutive adult patients</article-title><source>Ann Thorac Surg</source><year>2003</year><volume>75</volume><issue>2</issue><fpage>472</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1016/S0003-4975(02)04370-9</pub-id><pub-id pub-id-type="pmid">12607656</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>MAC</given-names></name><name><surname>Gauer</surname><given-names>MF</given-names></name><name><surname>Gomes</surname><given-names>RZ</given-names></name><name><surname>Schafranski</surname><given-names>MD</given-names></name></person-group><article-title>Risk factors for perioperative ischemic stroke in cardiac
surgery</article-title><source>Braz J Cir Cardiovasc</source><year>2015</year><volume>30</volume><issue>3</issue><fpage>365</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.5935/1678-9741.20150032</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirt</surname><given-names>LS</given-names></name></person-group><article-title>Progression rate and ipsilateral neurological events in
asymptomatic carotid stenosis</article-title><source>Stroke</source><year>2014</year><volume>45</volume><issue>3</issue><fpage>702</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.111.613711</pub-id><pub-id pub-id-type="pmid">21799164</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mickleborough</surname><given-names>LL</given-names></name><name><surname>Walker</surname><given-names>PM</given-names></name><name><surname>Takagi</surname><given-names>Y</given-names></name><name><surname>Ohashi</surname><given-names>M</given-names></name><name><surname>Ivanow</surname><given-names>J</given-names></name><name><surname>Tamariz</surname><given-names>M</given-names></name></person-group><article-title>Risk factors for stroke in patients undergoing coronary artery
bypass grafting</article-title><source>J Thorac Cardiovasc Surg</source><year>1996</year><volume>112</volume><issue>5</issue><fpage>1250</fpage><lpage>1258</lpage><pub-id pub-id-type="doi">10.1016/S0022-5223(96)70138-1</pub-id><pub-id pub-id-type="pmid">8911321</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naylor</surname><given-names>AR</given-names></name><name><surname>Rothwell</surname><given-names>PM</given-names></name><name><surname>Bell</surname><given-names>PRF</given-names></name></person-group><article-title>Overview of the principal results and secondary analyses from the
European and North American randomized trials of endarterectomy for
symptomatic carotid stenosis</article-title><source>Eur J Vasc Endovasc Surg</source><year>2003</year><volume>26</volume><issue>2</issue><fpage>115</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1053/ejvs.2002.1946</pub-id><pub-id pub-id-type="pmid">12917824</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lobo Filho</surname><given-names>JG</given-names></name><name><surname>Leit&#x000e3;o</surname><given-names>MCA</given-names></name><name><surname>Lobo Filho</surname><given-names>HG</given-names></name><name><surname>Soares</surname><given-names>JPH</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>GA</given-names></name><name><surname>Le&#x000e3;o Filho</surname><given-names>CSC</given-names></name></person-group><article-title>Cirurgia de revasculariza&#x000e7;&#x000e3;o Coronariana esquerda
sem CEC e sem manuseio da aorta em pacientes acima de 75
anos</article-title><source>Rev Bras Cir Cardiovasc</source><year>2002</year><volume>17</volume><issue>3</issue><fpage>208</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1590/S0102-76382002000300004</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1;</surname><given-names>MPBO</given-names></name><name><surname>Ferraz</surname><given-names>PE</given-names></name><name><surname>Escobar</surname><given-names>RR</given-names></name><name><surname>Martins</surname><given-names>WN</given-names></name><name><surname>Lustosa</surname><given-names>PC</given-names></name><name><surname>Nunes</surname><given-names>EO</given-names></name></person-group><article-title>Off-pump versus on-pump coronary artery bypass surgery
meta-analysis and meta-regression of 13,524 patients from randomized
trials</article-title><source>Rev Bras Cir Cardiovasc</source><year>2012</year><volume>27</volume><issue>4</issue><fpage>631</fpage><lpage>641</lpage><pub-id pub-id-type="doi">10.5935/1678-9741.20120106</pub-id><pub-id pub-id-type="pmid">23515737</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sedrakyan</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>AW</given-names></name><name><surname>Parashar</surname><given-names>A</given-names></name><name><surname>Bass</surname><given-names>EB</given-names></name><name><surname>Treasure</surname><given-names>T</given-names></name></person-group><article-title>Off-pump surgery is associated with reduced occurrence of stroke
and other morbidity as compared with traditional coronary artery bypass
grafting a meta-analysis of systematically reviewed trials</article-title><source>Stroke</source><year>2006</year><volume>37</volume><issue>11</issue><fpage>2759</fpage><lpage>2769</lpage><pub-id pub-id-type="doi">10.1161/01.STR.0000245081.52877.f2</pub-id><pub-id pub-id-type="pmid">17008617</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>SJ</given-names></name><name><surname>Mintz</surname><given-names>GS</given-names></name><name><surname>Weiz</surname><given-names>G</given-names></name><name><surname>Mehran</surname><given-names>R</given-names></name><name><surname>Rabbani</surname><given-names>LE</given-names></name><name><surname>Verheye</surname><given-names>S</given-names></name></person-group><article-title>Age-related effects of smoking on coronary artery disease
assessed by gray scale and virtual histology intravascular
ultrasound</article-title><source>Am J Cardiol</source><year>2015</year><volume>115</volume><issue>8</issue><fpage>1056</fpage><lpage>1062</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2015.01.535</pub-id><pub-id pub-id-type="pmid">25726380</pub-id></element-citation></ref></ref-list></back></article>